HomeCompareCOOSF vs ARCC

COOSF vs ARCC: Dividend Comparison 2026

COOSF yields 21.21% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 COOSF wins by $54.1K in total portfolio value
10 years
COOSF
COOSF
● Live price
21.21%
Share price
$9.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.6K
Annual income
$7,650.07
Full COOSF calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — COOSF vs ARCC

📍 COOSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCOOSFARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, COOSF + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
COOSF pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

COOSF
Annual income on $10K today (after 15% tax)
$1,802.60/yr
After 10yr DRIP, annual income (after tax)
$6,502.56/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, COOSF beats the other by $6,501.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of COOSF + ARCC for your $10,000?

COOSF: 50%ARCC: 50%
100% ARCC50/50100% COOSF
Portfolio after 10yr
$51.6K
Annual income
$3,825.62/yr
Blended yield
7.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

COOSF
No analyst data
Altman Z
0.1
Piotroski
3/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

COOSF buys
0
ARCC buys
0
No recent congressional trades found for COOSF or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCOOSFARCC
Forward yield21.21%10.82%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$78.6K$24.5K
Annual income after 10y$7,650.07$1.16
Total dividends collected$46.0K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: COOSF vs ARCC ($10,000, DRIP)

YearCOOSF PortfolioCOOSF Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$12,821$2,120.71$11,381$541.15+$1.4KCOOSF
2$16,259$2,541.03$12,621$284.08+$3.6KCOOSF
3$20,409$3,011.71$13,827$145.31+$6.6KCOOSF
4$25,371$3,533.07$15,062$73.43+$10.3KCOOSF
5$31,251$4,104.68$16,364$36.89+$14.9KCOOSF
6$38,164$4,725.33$17,757$18.49+$20.4KCOOSF
7$46,229$5,393.07$19,258$9.25+$27.0KCOOSF
8$55,570$6,105.32$20,880$4.63+$34.7KCOOSF
9$66,319$6,858.88$22,636$2.32+$43.7KCOOSF
10$78,611$7,650.07$24,539$1.16+$54.1KCOOSF

COOSF vs ARCC: Complete Analysis 2026

COOSFStock

Carbios SAS, a green chemistry company, develops industrial bioprocesses for the biodegradation and bio recycling of polymers in France. The company engages in the production of EVANESTO, an enzymatic biodegradation solution for polylactic acid (PLA) based single-use plastics; and enzymatic recycling of polyethylene terephthalate (PET). It also offers PLA, a biosourced and biodegradable plastic polymer; and recycles plastic waste into plastic materials. The company also exports its products. Carbios SAS has a development agreement with Novozymes to produce enzyme for recycling of PET-plastics and fibers. The company was incorporated in 2011 and is headquartered in Saint-Beauzire, France.

Full COOSF Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this COOSF vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

COOSF vs SCHDCOOSF vs JEPICOOSF vs OCOOSF vs KOCOOSF vs MAINCOOSF vs HTGCCOOSF vs GBDCCOOSF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.